TP53 MUTATIONS ARE INFREQUENT IN NEWLY-DIAGNOSED CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0

作者：

Murray, F. ^{[1
]}

Zainuddin, N. ^{[1
]}

Kanduri, M. ^{[1
]}

Gunnarsson, R. ^{[2
]}

Smedby, K. Ekstrom ^{[3
]}

Enblad, G. ^{[1
]}

Jurlander, I. ^{[4
]}

Juliusson, G. ^{[2
]}

Rosenquist, R. ^{[1
]}

机构：

[1] Uppsala Univ, Uppsala, Sweden

[2] Lund Univ, Lund, Sweden

[3] Karolinska Inst, Stockholm, Sweden

[4] Rigshosp, DK-2100 Copenhagen, Denmark

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0097

引用

页码：39 / 39

页数：1

共 50 条

[1] TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia
Zainuddin, Norafiza
Murray, Fiona
Kanduri, Meena
Gunnarsson, Rebeqa
Smedby, Karin E.
Enblad, Gunilla
Jurlander, Jesper
Juliusson, Gunnar
Rosenquist, Richard
LEUKEMIA RESEARCH, 2011, 35 (02) : 272 - 274
[2] The TP53 Codon72 Polymorphism Is Associated with TP53 Mutations in Chronic Lymphocytic Leukemia
Grossmann, Vera
Artusi, Valentina
Schnittger, Susanne
Dicker, Frank
Jeromin, Sabine
Boeck, Lucia
Haferlach, Torsten
Haferlach, Claudia
Kern, Wolfgang
Kohlmann, Alexander
BLOOD, 2011, 118 (21) : 778 - 778
[3] Selection of new TP53 mutations by therapy in chronic lymphocytic leukemia
Trbusek, Martin
Malcikova, Jitka
Mayer, Jiri
LEUKEMIA RESEARCH, 2011, 35 (07) : 981 - 982
[4] TP53 Aberrations in Chronic Lymphocytic Leukemia
Trbusek, Martin
Malcikova, Jitka
ADVANCES IN CHRONIC LYMPHOCYTIC LEUKEMIA, 2013, 792 : 109 - 131
[5] Clinical Impact of Clonal and Subclonal TP53 Mutations in Chronic Lymphocytic Leukemia
Bomben, Riccardo
Rossi, Maria Francesca
D'Agaro, Tiziana
Bittolo, Tamara
Zucchetto, Antonella
Tissino, Erika
Pozzo, Federico
Vit, Filippo
Bulian, Pietro
Degan, Massimo
Zaina, Eva
Cattarossi, Ilaria
Nanni, Paola
Chivilo, Hillarj
D'Arena, Giovanni Francesco
Chiarenza, Annalisa
Santinelli, Enrico
Zaja, Francesco
Pozzato, Gabriele
Di Raimondo, Francesco
Del Poeta, Giovanni
Gattei, Valter
BLOOD, 2018, 132
[6] Treatment Patterns and Outcomes of Patients with Chronic Lymphocytic Leukemia with TP53 Mutations
Hwang, Steven R.
Wang, Yucai
Rabe, Kari G.
He, Rong
Kenderian, Saad S.
Muchtar, Eli
Hampel, Paul J.
Kay, Neil E.
Call, Timothy G.
Koehler, Amber
Behnken, Amy L.
Leis, Jose F.
Braggio, Esteban
Shi, Min
Viswanatha, David S.
Van Dyke, Daniel L.
Slager, Susan L.
Parikh, Sameer A.
Ding, Wei
BLOOD, 2022, 140 : 12390 - 12392
[7] Ibrutinib for Chronic Lymphocytic Leukemia with TP53 Alterations
Ahn, Inhye E.
Tian, Xin
Wiestner, Adrian
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05): : 498 - 500
[8] TP53 Mutation and Survival in Chronic Lymphocytic Leukemia
Zenz, Thorsten
Eichhorst, Barbara
Busch, Raymonde
Denzel, Tina
Haebe, Sonja
Winkler, Dirk
Buehler, Andreas
Edelmann, Jennifer
Bergmann, Manuela
Hopfinger, Georg
Hensel, Manfred
Hallek, Michael
Doehner, Hartmut
Stilgenbauer, Stephan
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (29) : 4473 - 4479
[9] HIGH-THROUGHPUT SEQUENCING FOR THE IDENTIFICATION OF TP53 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
Barbieri, M.
Favoino, C.
Colombo, M.
Manzoni, M.
Cutrona, G.
Matis, S.
Fabris, S.
Gentile, M.
Recchia, A.
Bossio, S.
De Stefano, L.
Fama, A.
Vincoli, D.
Musolino, C.
Molica, S.
Cortelezzi, A.
Di Raimondo, F.
Morabito, F.
Ferrarini, M.
Neri, A.
Lionetti, M.
HAEMATOLOGICA, 2016, 101 : S26 - S26
[10] TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed?
Bomben, Riccardo
Zucchetto, Antonella
Pozzo, Federico
Tissino, Erika
Bittolo, Tamara
Olivieri, Jacopo
Chiarenza, Annalisa
Zaja, Francesco
Del Principe, Maria Ilaria
Rossi, Davide
Gattei, Valter
HEMASPHERE, 2023, 7 (04):

← 1 2 3 4 5 →